The pancreas lies below the lower part of the stomach and makes enzymes that help digest food and hormones that help manage blood sugar. Pancreatic cancer begins as a growth of cells in this organ.
The American Cancer Society’s estimates for pancreatic cancer in the United States for 2023 are:
- Approximately 64,050 people (33,130 men and 30,290 women) will be diagnosed with pancreatic cancer
- About 50,550 (26,620 men and 23,930 women) will die from this type of cancer
Here are 9 facts about Pancreatic Cancer –
Silent Symptoms: Pancreatic cancer is known as the “silent disease” for a reason. It typically exhibits very few symptoms until it has advanced significantly. Early detection is thus a challenging endeavor, underscoring the importance of regular check-ups and awareness.
The Role of the Pancreas: The pancreas serves a dual purpose in the body, producing digestive enzymes and hormones like insulin. When pancreatic cancer develops, it can disrupt both these critical functions, highlighting the far-reaching impact of the disease.
Difficult to Detect: Early screening for pancreatic cancer remains a challenge. It is often inadvertently discovered or when symptoms become evident, usually at an advanced stage. Researchers are working to develop more reliable screening methods.
Environmental and Genetic Factors: Smoking, obesity, excessive drinking, family history and specific genetic mutations (e.g., BRCA1, BRCA2) are associated with an increased risk of developing pancreatic cancer. Understanding these risk factors is important for early intervention and prevention.
Low Survival Rate: Pancreatic cancer has one of the lowest survival rates among major cancers, with an overall five-year survival rate of approximately 10%. Late-stage diagnosis is a primary reason for this grim statistic, emphasizing the need for better diagnostic methods.
Whipple Procedure: Surgical treatment for pancreatic cancer frequently involves the Whipple procedure, a complex surgery that may entail removing portions of the pancreas, bile duct, and small intestine. It’s a testament to the medical community’s dedication to improving patient outcomes.
Robotic Surgery: Innovations in medical technology have paved the way for robotic-assisted surgery in treating pancreatic cancer. This approach offers improved precision and shorter patient recovery times.
Immunotherapy Research: Groundbreaking research is underway to explore the potential of immunotherapy as a treatment for pancreatic cancer. Early-stage clinical trials have shown promising results, giving hope to patients and healthcare professionals.
Awareness and Advocacy: Organizations and individuals are rallying for greater awareness and research funding for pancreatic cancer. Their dedication is leading to increased support for patients and families facing this formidable disease.
Pancreatic cancer remains a challenging cancer to successfully treat, but the medical community is making significant strides in understanding, diagnosing and treating this disease. By supporting research efforts and enhancing awareness, we can work toward better outcomes for those affected by pancreatic cancer.
RETURN TO NEWS